Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03336112
Other study ID # I-CBT for NCCP
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2017
Est. completion date July 31, 2021

Study information

Verified date March 2023
Source Linkoeping University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Non-cardiac chest pain (NCCP) is common and has substantial impact on patients' psychological wellbeing, quality of life and healthcare use. Although cardiac diagnosis is 'ruled out', many patients think they have an undetected cardiac disease (i.e. they suffer cardiac anxiety) as no other explanation is offered. They therefore avoid activities that they believe might be harmful to their heart, leading to greater ill-health, and increased healthcare use and societal costs. Targeting cardiac anxiety with psychological interventions might break this vicious circle and improve patient outcomes. Patients need to evaluate the way they perceive and handle their chest pain, which can be done with cognitive behavioral therapy (CBT). The aim of this study is therefore to evaluate the short- and long-term effects of an Internet-delivered CBT (I-CBT) program on psychological distress and other patient-reported outcomes in patients with NCCP. A second aim is to explore factors related to implementation of I-CBT in clinical care. The study has a randomized controlled design comparing I-CBT with Internet-delivered information program. Quantitative methods will be used to evaluate the effectiveness of the I-CBT program. Implementation issues will be evaluated from the perspectives of patients, healthcare professionals and policymakers using qualitative methods.


Recruitment information / eligibility

Status Completed
Enrollment 109
Est. completion date July 31, 2021
Est. primary completion date October 9, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - at least 2 healthcare visits due to NCCP during the last 6 months - patients suffering from cardiac anxiety (score = 24 on the Cardiac Anxiety Questionnaire-CAQ) Exclusion Criteria: - language difficulties - not able to perform physical activity/exercise due to physical constraints - patients with severe depressive symptoms - patients with acute ischemic heart disease - patients with no access to computer/tablet and/or Internet

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Internet-delivered cognitive behavioral therapy (I-CBT)
The intervention (I-CBT) will consist of 5 weeks of Internet-delivered cognitive behavioral therapy using three main parts. The first is psychoeducation that aims to educate the patients about chest pain and other causes than the cardiac ones. The other part concerns avoidance and exposure. This includes exposing the patients to physical activities that patients perceive as a threat to the heart. The third part contains awareness (mindfulness) training to teach the patients to have contact with the present moment despite chest pain and not trying to avoid it.
Other:
Information program
Information program delivered by the Internet during 5 weeks.

Locations

Country Name City State
Sweden Linköping University Linköping

Sponsors (2)

Lead Sponsor Collaborator
Linkoeping University Ostergotland County Council, Sweden

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cardiac anxiety Cardiac Anxiety Questionnaire (CAQ) will be used before and after the intervention (5 weeks), and 3, 6, 12 months after the end of the intervention to assess changes related to intervention. The CAQ consists of 18 items and a score range between 0 and 72. The higher scores the greater cardiac anxiety. 12 months after end of intervention
Secondary Fear of body sensations Body Sensations Questionnaire will be used before and after the intervention (5 weeks), and 3, 6, 12 months after the end of the intervention to assess changes related to intervention. The questionnaire comprises 17 items with scores ranging between 17 and 85 and the higher scores the greater fear of body sensations. 12 months after end of intervention
Secondary Depressive symptoms Patient Health Questionnaire-9 will be used before and after the intervention (5 weeks), and 3, 6, 12 months after the end of the intervention to assess changes related to intervention. This questionnaire comprises 9 items with scores ranging between 0 and 27. Higher scores indicate higher levels of depressive symptoms. A cut-off of 10 demonstrates moderate levels and will be used in this study. 12 months after end of intervention
Secondary Health-related quality of life EuroQol-5D (EQ-5D) will be used before and after the intervention (5 weeks), and 3, 6, 12 months after the end of the intervention to assess changes related to intervention. The EQ-5D includes five dimensions of Health-related quality of life: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has five levels corresponding to: no problems, slight problems, moderate problems, severe problems and extreme problems/unable. The questionnaire also includes an EQ-VAS, which is a visual analogue scale ranging from 0 (worst health you can imagine) to 100 (best health you can imagine). 12 months after end of intervention
Secondary Chest pain frequency Self-developed open questions will be used before and after the intervention (5 weeks), and 3, 6, 12 months after the end of the intervention to assess changes in chest pain related to intervention. 12 months after end of intervention
Secondary Healthcare use Care Data Warehouse (Register), data will be collected 12 months after the end of the intervention to assess changes related to intervention. 12 months after end of intervention
Secondary Societal costs Cost per patient register and Social Insurance Office register, data will be collected 12 months after the end of the intervention to assess changes related to intervention. 12 months after end of intervention
See also
  Status Clinical Trial Phase
Terminated NCT00164801 - Effect of GABAB Agonist on Visceral Hyperalgesia in NCCP patientsChinese? N/A
Recruiting NCT06136494 - iCBT for Cardiac Anxiety in Patients With NCCP N/A
Completed NCT00373828 - Non-cardiac Chest Pain Evaluation and Treatment Study (CARPA) - Part 1: Diagnosis. N/A
Completed NCT00476398 - Evaluation of Patients With Non-cardiac Chest Pain Phase 4
Completed NCT00462241 - Treatment Study Comparing Manual Treatment or Advice in Acute, Musculoskeletal Chest Pain N/A
Terminated NCT00164814 - The Role of Visceral Hyperalgesia, Gastroesophageal Reflux Disease (GERD) and Esophageal Motility Disorder (EMD) in NCCP Patients N/A